Tsuyoshi Hirose

514 total citations
15 papers, 417 citations indexed

About

Tsuyoshi Hirose is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Tsuyoshi Hirose has authored 15 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 5 papers in Psychiatry and Mental health. Recurrent topics in Tsuyoshi Hirose's work include Neurotransmitter Receptor Influence on Behavior (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and Receptor Mechanisms and Signaling (4 papers). Tsuyoshi Hirose is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and Receptor Mechanisms and Signaling (4 papers). Tsuyoshi Hirose collaborates with scholars based in Japan, United States and Spain. Tsuyoshi Hirose's co-authors include Tetsuro Kikuchi, Hisashi Kitagawa, Takashi Miwa, Yasufumi Uwahodo, Sakiko Yamada, C. Anthony Altar, Kevin D. Burris, Kenji Maeda, Toshitaka Nabeshima and Takashi Futamura and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Pharmacology and Journal of Endocrinology.

In The Last Decade

Tsuyoshi Hirose

15 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tsuyoshi Hirose Japan 9 179 171 94 62 41 15 417
Felix-Martin Werner Spain 12 147 0.8× 116 0.7× 106 1.1× 54 0.9× 37 0.9× 24 407
Georg Nikisch Germany 12 203 1.1× 146 0.9× 88 0.9× 99 1.6× 47 1.1× 17 588
Shivakumar Kolachalam Italy 9 134 0.7× 163 1.0× 200 2.1× 42 0.7× 28 0.7× 13 500
Patricia M. Whitaker Canada 10 317 1.8× 127 0.7× 197 2.1× 59 1.0× 38 0.9× 12 484
Jeffrey K Yao United States 7 102 0.6× 116 0.7× 113 1.2× 33 0.5× 38 0.9× 9 469
Stefano Aringhieri Italy 7 125 0.7× 148 0.9× 185 2.0× 35 0.6× 28 0.7× 7 453
Tomoko Horisawa Japan 8 242 1.4× 283 1.7× 157 1.7× 99 1.6× 52 1.3× 10 558
Judit Laszy Hungary 10 275 1.5× 179 1.0× 184 2.0× 69 1.1× 74 1.8× 18 528
Yi-Chyan Chen Taiwan 15 165 0.9× 78 0.5× 122 1.3× 66 1.1× 56 1.4× 26 560
Tomoya Okada Japan 8 190 1.1× 67 0.4× 52 0.6× 73 1.2× 71 1.7× 13 323

Countries citing papers authored by Tsuyoshi Hirose

Since Specialization
Citations

This map shows the geographic impact of Tsuyoshi Hirose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsuyoshi Hirose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsuyoshi Hirose more than expected).

Fields of papers citing papers by Tsuyoshi Hirose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsuyoshi Hirose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsuyoshi Hirose. The network helps show where Tsuyoshi Hirose may publish in the future.

Co-authorship network of co-authors of Tsuyoshi Hirose

This figure shows the co-authorship network connecting the top 25 collaborators of Tsuyoshi Hirose. A scholar is included among the top collaborators of Tsuyoshi Hirose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsuyoshi Hirose. Tsuyoshi Hirose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Amada, Naoki, et al.. (2023). Synergistic anti‐depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice. Neuropsychopharmacology Reports. 43(1). 132–136. 7 indexed citations
2.
Kikuchi, Tetsuro, et al.. (2021). Discovery research and development history of the dopamine D2 receptor partial agonists, aripiprazole and brexpiprazole. Neuropsychopharmacology Reports. 41(2). 134–143. 34 indexed citations
3.
Takahashi, Eiki, et al.. (2017). Long range wireless SAW passive tag system for vibration monitoring. 2017 IEEE International Ultrasonics Symposium (IUS). 1–1. 2 indexed citations
4.
Hirose, Tsuyoshi, et al.. (2010). Chronic hyponatremia impairs memory in rats: effects of vasopressin antagonist tolvaptan. Journal of Endocrinology. 206(1). 105–111. 20 indexed citations
5.
Nakai, Satoru, Tsuyoshi Hirose, Toyoki Mori, et al.. (2007). THE EFFECT OF ARIPIPRAZOLE ON PREPULSE INHIBITION OF THE STARTLE RESPONSE IN NORMAL AND HYPERDOPAMINERGIC STATES IN RATS. International Journal of Neuroscience. 118(1). 39–57. 11 indexed citations
6.
Maeda, Kenji, Haruhiko Sugino, Tsuyoshi Hirose, et al.. (2007). Clozapine Prevents a Decrease in Neurogenesis in Mice Repeatedly Treated With Phencyclidine. Journal of Pharmacological Sciences. 103(3). 299–308. 59 indexed citations
7.
Hirose, Tsuyoshi, et al.. (2006). The antipsychotic drug aripiprazole (ABILIFY<sup>&reg;</sup>). Folia Pharmacologica Japonica. 128(5). 331–345. 4 indexed citations
8.
Hirose, Tsuyoshi & Tetsuro Kikuchi. (2005). Aripiprazole, a novel antipsychotic agent: Dopamine D2 receptor partial agonist. The Journal of Medical Investigation. 52(Supplement). 284–290. 67 indexed citations
9.
Hirose, Tsuyoshi, Yasufumi Uwahodo, Sakiko Yamada, et al.. (2004). Mechanism of Action of Aripiprazole Predicts Clinical Efficacy and a Favourable Side-Effect Profile. Journal of Psychopharmacology. 18(3). 375–383. 116 indexed citations
10.
Nakai, Satoru, Tsuyoshi Hirose, Yasufumi Uwahodo, et al.. (2003). Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone. European Journal of Pharmacology. 472(1-2). 89–97. 39 indexed citations
11.
Inoue, Atsuko, Izumi Hide, Tsuyoshi Hirose, et al.. (1998). Differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary. Molecular Brain Research. 55(2). 285–292. 32 indexed citations
12.
Kikuchi, Tetsuro, Yasufumi Uwahodo, Masami Nakai, et al.. (1995). Protective effects of OPC-14117 on dopaminergic neuronal degeneration induced by MPTP in ICR mice. The Japanese Journal of Pharmacology. 67. 144–144. 3 indexed citations
15.
Oshiro, Yasuo, et al.. (1991). Novel cerebroprotective agents with central nervous system stimulating activity. 2. Synthesis and pharmacology of the 1-(acylamino)-7-hydroxyindan derivatives. Journal of Medicinal Chemistry. 34(7). 2014–2023. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026